FDA Inspection 1245147 — Premier Biotech, Inc.
The FDA completed an inspection of Premier Biotech, Inc. on July 23, 2024 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 23, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Minneapolis, MN (United States)